Interestingly, KMT2A–MLLT3+ disease in infants presents more often as ALL than AML, whereas the phenotype changes into a typical myelo-monocytic AML M5 with increasing age of the patient. This evidence concerns the gene MLLT3 and acute lymphoblastic leukemia.